» Articles » PMID: 15143186

Signaling Specificity by Ras Family GTPases is Determined by the Full Spectrum of Effectors They Regulate

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2004 May 15
PMID 15143186
Citations 141
Authors
Affiliations
Soon will be listed here.
Abstract

Ras family GTPases (RFGs) regulate signaling pathways that control multiple biological processes. How signaling specificity among the closely related family members is achieved is poorly understood. We have taken a proteomics approach to signaling by RFGs, and we have analyzed interactions of a panel of RFGs with a comprehensive group of known and potential effectors. We have found remarkable differences in the ability of RFGs to regulate the various isoforms of known effector families. We have also identified several proteins as novel effectors of RFGs with differential binding specificities to the various RFGs. We propose that specificity among RFGs is achieved by the differential regulation of combinations of effector families as well as by the selective regulation of different isoforms within an effector family. An understanding of this new level of complexity in the signaling pathways regulated by RFGs is necessary to understand how they carry out their many cellular functions. It will also likely have critical implications in the treatment of human diseases such as cancer.

Citing Articles

T Cell-Specific Inactivation of the PI3K p110α Catalytic Subunit: Effect in T Cell Differentiation and Antigen-Specific Responses.

Briones A, Del Estal L, Villa-Gomez C, Bermejo V, Cervera I, Gutierrez-Huerta P Int J Mol Sci. 2025; 26(2).

PMID: 39859310 PMC: 11765243. DOI: 10.3390/ijms26020595.


Structural insights into isoform-specific RAS-PI3Kα interactions and the role of RAS in PI3Kα activation.

Czyzyk D, Yan W, Messing S, Gillette W, Tsuji T, Yamaguchi M Nat Commun. 2025; 16(1):525.

PMID: 39788953 PMC: 11718114. DOI: 10.1038/s41467-024-55766-x.


Mediating kinase activity in Ras-mutant cancer: potential for an individualised approach?.

Healy F, Turner A, Marensi V, MacEwan D Front Pharmacol. 2024; 15:1441938.

PMID: 39372214 PMC: 11450236. DOI: 10.3389/fphar.2024.1441938.


Grb7, Grb10 and Grb14, encoding the growth factor receptor-bound 7 family of signalling adaptor proteins have overlapping functions in the regulation of fetal growth and post-natal glucose metabolism.

Moorwood K, Smith F, Garfield A, Cowley M, Holt L, Daly R BMC Biol. 2024; 22(1):221.

PMID: 39343875 PMC: 11441139. DOI: 10.1186/s12915-024-02018-5.


Co-targeting SOS1 enhances the antitumor effects of KRAS inhibitors by addressing intrinsic and acquired resistance.

Thatikonda V, Lyu H, Jurado S, Kostyrko K, Bristow C, Albrecht C Nat Cancer. 2024; 5(9):1352-1370.

PMID: 39103541 PMC: 11424490. DOI: 10.1038/s43018-024-00800-6.


References
1.
Ortiz-Vega S, Khokhlatchev A, Nedwidek M, Zhang X, Dammann R, Pfeifer G . The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1. Oncogene. 2002; 21(9):1381-90. DOI: 10.1038/sj.onc.1205192. View

2.
Khokhlatchev A, Rabizadeh S, Xavier R, Nedwidek M, Chen T, Zhang X . Identification of a novel Ras-regulated proapoptotic pathway. Curr Biol. 2002; 12(4):253-65. DOI: 10.1016/s0960-9822(02)00683-8. View

3.
Murphy G, Graham S, Morita S, Reks S, Vojtek A, Kelley G . Involvement of phosphatidylinositol 3-kinase, but not RalGDS, in TC21/R-Ras2-mediated transformation. J Biol Chem. 2002; 277(12):9966-75. DOI: 10.1074/jbc.M109059200. View

4.
Spencer M, Shao H, Andres D . Induction of neurite extension and survival in pheochromocytoma cells by the Rit GTPase. J Biol Chem. 2002; 277(23):20160-8. DOI: 10.1074/jbc.M201092200. View

5.
Light Y, Paterson H, Marais R . 14-3-3 antagonizes Ras-mediated Raf-1 recruitment to the plasma membrane to maintain signaling fidelity. Mol Cell Biol. 2002; 22(14):4984-96. PMC: 139778. DOI: 10.1128/MCB.22.14.4984-4996.2002. View